서울특별시생리학

11th International Human Microbiome Consortium (제11차 국제 인체마이크로바이옴 콘소시엄 학술대회) Day 3

Name: 11th International Human Microbiome Consortium (제11차 국제 인체마이크로바이옴 콘소시엄 학술대회) Day 3
Start: 2026-06-05
End: 2026-06-05
Location: 코엑스 서울

6점 일반 6

주최: 대한면역학회
일자: 2026-06-05
장소: 코엑스 서울
수강료: 1,380,000원 구분별

수강료 구분별 상세보기

early 학생 45만원, early 일반 108만원, regular 학생 60만원

원문 기준 · 정확한 등록비는 KMA 신청 페이지에서 확인하세요.

평점 구성

총 평점6점

필수평점0점

일반평점6점

연수평점은 3년 24점·연 8점 상한·필수 2점 요건이 있습니다. 이 행사 들으면 올해 상한까지 몇 점? →

KMA 등록 페이지에서 신청 → 평점 계산기

세부 일정 (45강)

09:00~09:30 Host-Microbiome Cross-Talk Shaping Immunity, Metabolism, and Ageing Trajectories GB101 Eran Elinav(Weizmann Institute of Science, Israel)
09:30~10:00 Can We Modulate the Gut Microbiome Through Nutritional Interventions to Extend Healthy Lifespan? GB101 Jens Walter(University College Cork, Ireland)
10:00~10:30 The Human Gut Microbiome as a Key Mediator of Frailty and Healthy Aging GB101 Sean Gibbons(Institute for Systems Biology, USA)
10:30~11:00 Roundtable Panel Discussion GB101 Ruth Ley, Jingyuan Fu(Max Planck Institute for Biology Tübingen, Germany)
09:00~09:30 Innovative Microbiome Analysis Reveals Parkinson's Disease Signature in Healthy Individuals Auditorium Stanislav Dusko Ehrlich(University College London, UK)
09:30~09:45 Mechanistic Dissection of Epithelial–Neural Alpha-Synuclein Transmission in Parkinson’s Disease Using a Human ENS-on-a-Chip Auditorium Jieun Kim(Korea Advanced Institute of Science and Technology, Korea)
09:45~10:00 Therapeutic Potential and Underlying Mechanisms of Gut Microbiota in Restoring Neurodevelopment in Autism Spectrum Disorder Auditorium Qi Su(Chinese University of Hong Kong, Hong Kong)
10:00~10:30 Bridging the Gut and the Brain by Immune Cell Trafficking Auditorium Eunha Kim(Korea University, Korea)
10:30~11:00 Understanding the Gut Microbiome in Autism Spectrum Disorder: Lessons from the Australian Autism Biobank Auditorium Jake Gratten(The University of Queensland, Australia)
09:00~09:30 A Non Immunosuppressive Faecalibacterium Based Therapeutic for IBD Driven by Treg Induction and Metabolite Mediated Barrier Restoration GB105 Chang-Sik Shin (CJ Bioscience, Korea)
09:30~10:00 Development of a Microbiome-Based Therapeutic for the Treatment of Psoriasis by Targeting the Gut-Skin Axis GB105 Sang Kyun Lim (KoBioLabs, Korea)
10:00~10:30 CMC Solutions for Live Biotherapeutics and Next-Generation Probiotics: A CDMO Perspective for Biotechs and Academic Spinouts GB105 Richard Ellis (Biose, France)
10:30~11:00 From Nutraceutical to Pharmaceutical: A Dual-Track Development Strategy for Pasteurized Akkermansia muciniphila HB05P Targeting Muscle Health and Sarcopenia GB105 Jay Lee(Health Biome, Korea)
11:10~12:00 Pleanary Lecture 3 Personalized Medicine Based on Microbiome and Multi-Omics Profiling of a large-scale cohort Auditorium Eran Segal(Weizmann Institute of Science, Israel)
13:30~13:45 Maternal Viral Sharing and Limited Virulent Replication Shape Early Infant Gut Virome Maturation GB101 Kim Kreuze(University of Helsinki, Finland)
13:45~14:00 Role of Maternally Transmitted Strains in the Early-Life Microbiome and Child Health GB101 Ching Jian(University of Helsinki, Finland)
14:00~14:15 HiFi Long-Read Metagenomic Sequencing Reveals Strain Replacement After Antibiotic-Pretreated FMT in Ulcerative Colitis GB101 Hikaru Watanabe( Metagen Therapeutics, Japan)
14:15~14:30 Real World Effectiveness and Strain-Level Exploration of Fecal Microbiota Transplantation in Treating Recurrent Hepatic Encephalopathy GB101 Yizhou Zhang(Shulan Hangzhou Hospital, China)
14:30~14:45 Microbial Strain Transmission Between Infants in Nurseries Drives Gut Microbiome Development GB101 Liviana Ricci(University of Trento, Italy)
14:45~15:00 Mom Matters: Maternal Influences on Infant Gut Microbiome and Health in 714 Mother-Infant Pairs in the Lifelines NEXT Cohort GB101 Trishla Sinha(Unversity Medical Center Groningen, Netherlands)
15:00~15:30 Regulation of Early Life Immunity by the Gut Microbiota GB101 Melody Zeng(Weill Cornell Medicine, USA)
13:30~14:00 Gut Microbial Signals for Regulating Neural Circuits Underlying Behavior Auditorium Elaine Hsiao(UCLA, USA)
14:00~14:30 Gut Symbiont-Derived Glycosphingolipid Facilitates Neonatal Colonization and Host-Microbiome Co-adaptation Auditorium Sungwhan F. Oh(Harvard Medical School, USA)
14:30~15:00 Dietary Modulation of Microbiome–Metabolite Interactions in the Gut–Organ Axis Auditorium Hyun Ju You(Seoul National University, Korea)
15:00~15:30 Lipidome Signatures Associated with Aging and the Host-Microbiome Interactions Auditorium Makoto Arita(RIKEN, Japan)
13:30~14:00 Microecological Research Progress in China GB105 Lanjuan Li(Zhejiang University, China)
14:00~14:30 Next Generation Probiotics in Liver Disease GB105 Ki-Tae Suk(Hallym University College of Medicine, Korea)
14:30~14:45 Thomasclavelia ramosa as a Defined Microbiome-Derived GB105 Lim Song(Seoul National University, Korea)
14:45~15:00 Pretreatment Gut Microbiome Profiles Predict Methotrexate Response in Treatment-Naïve Rheumatoid Arthritis GB105 Jaeyun Sung(Mayo Clinic, USA)
15:00~15:30 Interplay of Microbe-Epithelia-Immune System in Maintaining Gut Homeostasis GB105 Kyung-Gu Jang(Yonsei University College of Medicine, Korea)
15:45~16:15 The French Gut Project: Early Findings From an Expanding 100,000-Citizen-Scientist Cohort. GB101 Patrick Veiga(MetaGenoPolis/Le French Gut Project, INRAE, France)
16:15~16:45 Ecological Perspectives on the Human Microbiome GB101 Bong-Soo Kim(Ewha Womans University, Korea)
16:45~17:15 Korean Skin Microbiome Inventory for Aging and Skin Disorders GB101 Woo Jun Sul (Chung-Ang University, Korea)
17:15~17:30 Early-Life Dynamics of Mutagen-Producing Gut Microbes Linked to Early-Onset Colorectal Cancer GB101 Soyeon Kim(Wellcome Sanger Institute, United Kingdom)
17:30~17:45 Characterising Microbial Signatures Associated With Response To Faecal Microbiota Transplantation In Patients With Ulcerative Colitis GB101 Shreeya Sanjay Raich(The University of New South Wales, Australia)
15:45~16:15 Microbiota Modulate Cancer Immunity and Immunotherapy Auditorium Jun Yu(The Chinese University of Hong Kong, China)
16:15~16:45 Microbial Metabolites Linking the Gut Microbiome and the Host Auditorium Ara Koh(POSTECH, Korea)
16:45~17:15 Host-Microbiota Interaction in Inflammatory Bowel Diseases Auditorium Kiyoshi Takeda(Osaka Univ, Japan)
17:15~17:30 Metabolite-Driven Urobiome Reprogramming Governs Host Susceptibility to Bacterial Cystitis Auditorium Hae Woong Choi(Korea University, Korea)
17:30~17:45 Selective β-Glucoside Utilization Enables Ecological Enrichment of Lactobacillus Crispatus in the Vaginal Microbiome Auditorium Dominick J Jenkins(Harvard University, USA)
15:45~16:15 Engineering Microbes for Dynamic Host-Microbiome Modulation GB105 Matthew Wook Chang(National Univ of Singapore, Singapore)
16:15~16:45 AI-based Synthetic Biology Approaches to Engineer Cellular Phenotype GB105 Hyun Uk Kim(KAIST, Korea)
16:45~17:00 Biomolecular Phase Separation Suppresses Gene Expression in Bacteria GB105 Dongheon Lee(FAMU FSU College of Engineering, USA)
17:00~17:15 Programmable Encapsulation of Engineered Probiotics for Targeted Immunotoxin Delivery and Validation in a Colorectal Cancer-on-a-Chip GB105 Sungchan Cho(Korea Advanced Institute of Science and Technology, Korea)
17:15~17:45 Engineering Bifidobacterium to Modulate Host–Microbe Interaction for Oxalate Homeostasis and Kidney Stone Prevention GB105 Dae-Hee Lee(KRIBB, Korea)